This study focused on two primary areas: 1. To determine what can be learned from biotech and drug development companies that suffered from financial problems and ultimately failed at the beginning of the 21st century. 2. To determine how intellectual capital developed in accordance with such...

The turnover of the companies in North Savo in 2011 was nearly 10 billion euros, of which industry accounted for just under a third. The industrial structure of the region is not strong, but on the other hand it is not alarmingly thin either, because it does have certain successful niches. North...

This report is an overview to the presentations and discussions in the seminar Survival or performance? Healthcare viewed through organization, information management, and personnel held on 3.9.2012. The seminar provided an interdisciplinary forum for the question how the health care system may...

In this paper our aim is to assess the evolution of the Finnish biotechnology sector during the 2000s. Particular focus is given to the growth expectations and realized outcomes of Finnish biotechnology companies, to the evolution of public investments, and to potential determinants of company...

This paper utilizes queuing models to analyze health care processes. We extend previous queuing models to allow for i) heterogeneous resources, ii) resource allocation to various tasks, and iii) teams (complementary resources). We model a process of one clinical unit. We use the model to analyze...

This book analyses features of the Finnish forest biotechnology applications from three complementary perspectives: 1. What current biotechnology projects and resources are steered towards forest applications? 2. How much does the Finnish forest cluster invest in biotechnology R&D, and what are...

In this paper our aim is to assess the potential of using patent statistics in predicting the future sales anticipations and present value of a company active in the science-based industry. Instead of using conventional patent and patent application counts as indicators, we constructed patent...

Tässä tutkimuksessa simuloidaan lääkekehitykseen suuntautuneiden pienten ja keskisuurten biotekniikkayritysten tulevaisuutta, erityispainopisteenä kansantaloudelliset implikaatiot. Simulaatiossa huomioidaan vaihtoehtoisia kehityspolkuja, joiden avulla on arvioitu erilaisten...

New technological applications are usually expected to increase the health care costs. But they can also spawn cost savings in the long run, for example, when making time-consuming diagnostic methods more efficient and facilitating targeted therapy. This study analyses how the implementation of...